Skip to main content
OpenTrials
Completed

NCT Number: NCT03843281

Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department

The purpose of this study is to test the additional effect of paracetamol in combination with morphine for analgesia, respectively to test/confirm an opioid sparing effect due to the additional use of Paracetamol, as well as the reduction of adverse drug reactions of morphine.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Kantonsspital St.Gallen

Sankt Gallen, 9007, Switzerland

About this study

Paracetamol (acetaminophen) is widely used around the world for mild to moderate pain in all age groups. Prescription at the emergency department is very common and some studies suggest the use in alternative of Morphine, at least in the renal colic.

Morphine has also a complex analgesic effect due to inhibition of µ Receptors in the central nervous system and in the dorsal horn of the spinal cord. Morphine (like other opioids) is accepted as a cornerstone of acute pain management in the emergency department. However, occurrence of adverse drug reactions is up to 25%, mainly nausea and drowsiness.

The use of paracetamol in addition to morphine showed in a meta-analysis in the post-operative setting an opioid sparing effect of 20% over the first postoperative 24 hours, but did not change the incidence of morphine-related adverse effects in the postoperative period. An additive effect was showed of the two medicaments in another Study measuring the median effective analgesic dose (ED50).

The purpose of this study is to test the additional effect of paracetamol in combination with morphine for analgesia, respectively to test/confirm an opioid sparing effect due to the additional use of Paracetamol, as well as the to reduction of adverse drug reactions of morphine.

The study is a multicenter, randomized, double-blind, placebo-controlled. We randomize patients with pain-score >=4 on a pain Scala of 0-10 Points (numeric rating scale) in two group, one with paracetamol, one with placebo to investigate the (additive) effect of paracetamol in combination with morphine. The treatment team and the patients will be blinded to the administration. The study design is outlined to confirm the result of previous studies who stated a 20% reduction of morphine doses when combined with paracetamol. Study duration for each patient would be 240 min.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with pain with Pain-score is more or equal than four in a numeric rating scale from zero to ten (i.e. indication for a treatment with morphine)
  • Age over 18
  • Signed informed consent. In case, patient is not able to sign the informed consent due to pain, at least verbal consent has to be provided. After pain relief, written informed consent with data and time has to be obtained

Exclusion criteria

  • Analgesia in the past last 6 hours prior to visit at the emergency department
  • Current Analgesia with long-acting/extended-release drugs
  • Current Analgesia with opioids
  • Chronic pain syndrome
  • Contraindication for either paracetamol or morphine
  • Patient's refusal of paracetamol or morphine treatment
  • Pregnancy or Breastfeeding
  • GCS < 13
  • SpO2 < 90% with a maximum of 4 L/Min O2
  • Systolic Blood Pressure < 90 mmHg
  • "Fast Track"/Notfallpraxis patients

Treatment and study plan

Paracetamol

Drug

s. above

Other names: Paracetamol Sintetica

Placebo

Drug

s. above

Other names: NaCl 0.9%

Morphine

Drug

s. above

Other names: Morphine Sintetica

Primary outcomes

  1. Assessment of the total dose of morphine till pain < 4 on the NRS (0-10) after the first infusion of paracetamol or placebo.

    Time frame: up to 4 hours

Secondary outcomes

  1. Assessment of time interval of pain < 4 on the NRS (after been achieved)

    Time frame: up to 4 hours

  2. Total dose of morphine within the first 4 hours after the first infusion of paracetamol or Placebo.

    Time frame: up to 4 hours

  3. Prevalence of morphine adverse reactions within the first 4 hours after infusion of paracetamol or placebo

    Time frame: up to 4 hours, respectively in case of serious adverse events up to recovery time of the patient

Other outcomes

  1. Maximal Dose of Morphine based on adverse events

    Time frame: up to 4 hours

    A maximal Dose of opioids has been defined in our daily practice and in several guidelines with a precise number (e.g. 20 mg/4 h). In this trial we will use instead a maximal Dose defined with clinical criteria (GCS < 13, SpO2 < 90% with 4 L/min O2, uncontrolled vomiting). Assessment intended as occurrence of adverse events of the application of a such algorithms will be outcome of interest (not a secondary outcome because absence of a control group)

Sponsors and collaborators

Lead sponsor

Bruno Minotti

Other

Registry information

Official study title

Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Acronym: ParaMoED

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Feb 18, 2019
Registry last updated
Oct 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.